ArticleGastroenterology report2021

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.

Atsushi Hiraoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.